Nephrolyx
Paul Gentil has a diverse work experience in the scientific field. Paul is currently working as the Head of Analytical Lab at Nephrolytix since February 2022. Prior to this, they worked at FyoniBio as an Engineer Bio analytic from January 2021 to February 2022. Paul also held the position of Engineer Instrumental Bioanalytics at Glycotope GmbH from October 2018 to February 2022. Paul's earlier experience includes working as a University Student at University Lille 1 - PhLAM from September 2016 to January 2021. Paul also had a Research Development Internship at Glycotope GmbH from February 2018 to August 2018 and an Internship at Freie Universität Berlin from April 2017 to August 2017.
Paul Gentil attended the University of Lille 1 Sciences and Technology from 2016 to 2018. During this time, they pursued a Master 2 (M2) degree in Biotechnologie.
This person is not in the org chart
This person is not in any teams
Nephrolyx
Nephrolyx offers a precise and rapid measurement of the kidney function (true GFR). We provide hospitals and laboratories with an In-Vitro Diagnostic Test and a digital platform to measure the true GFR within only a few hours. For the first time, physicians can detect renal diseases using the highest accuracy of GFR measurement and adapt an optimal treatment plan for patients. Especially nephrology, oncology, transplantation, and ICU patients can benefit from rapid and precise diagnostics. The Nephrolyx IVDx is indicated for the in-vitro quantitative determination of serum iohexol concentration and calculation of the glomerular filtration rate (GFR). The principle of the test is based on Ultra-High-Performance-Liquid Chromatography using Ultra-Violet light. Proprietary technology from Nephrolyx helps to improve treatment success for kidney patients. Given its low component cost, the Nephrolyx IVDx can also significantly enhance the performance of the entire healthcare system.